Published in JAMA on January 18, 1985
Human immunodeficiency virus and drug misuse: the Edinburgh experience. Br Med J (Clin Res Ed) (1987) 2.37
Does infection with HIV affect the outcome of pregnancy? Br Med J (Clin Res Ed) (1988) 2.01
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol (1995) 1.77
The natural history of human T lymphotropic virus-III infection: the cause of AIDS. Br Med J (Clin Res Ed) (1986) 1.69
Prevention of AIDS and HIV infection: needs and priorities for epidemiologic research. Am J Public Health (1988) 1.59
Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J Clin Invest (1994) 1.41
Guidelines for the control of perinatally transmitted human immunodeficiency virus infection and care of infected mothers, infants and children. West J Med (1987) 1.22
Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine. Obstet Gynecol (1995) 1.17
Engaging HIV care providers in conversations with their reproductive-age patients about fertility desires and intentions: a historical review of the HIV epidemic in the United States. Am J Public Health (2013) 1.11
Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection. J Virol (1991) 0.96
Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. J Virol (1998) 0.92
Sero survey of human immunodeficiency virus infection in women at a family planning clinic: absence of infection in an indigent population in San Francisco. Am J Public Health (1989) 0.90
Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response. PLoS One (2009) 0.90
Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission. J Virol (1998) 0.86
AIDS and the obstetrician-gynecologist. J Natl Med Assoc (1987) 0.75
Effect of successive single-gestation pregnancies on the course of maternal human immunodeficiency virus disease and perinatal transmission. Infect Dis Obstet Gynecol (1995) 0.75
[Obstetric procedures in HIV infection]. Arch Gynecol Obstet (1989) 0.75
Drug abuse and human immunodeficiency virus infection in Scotland. J R Soc Med (1987) 0.75
AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families: clinical experience at Yale-New Haven Hospital. Yale J Biol Med (1988) 0.75
Drugs, poverty, pregnancy, and foster care in Los Angeles, California, 1989 to 1991. West J Med (1995) 0.75
Heterosexual and perinatal transmission of human immunodeficiency virus in a low prevalence community. West J Med (1988) 0.75
Congenital AIDS: review of neurologic problems. Childs Nerv Syst (1989) 0.75
Human immunodeficiency virus infection in pregnancy. Can J Infect Dis (1998) 0.75
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science (1986) 7.81
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science (1992) 7.44
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J Virol (1973) 5.28
Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 5.02
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A (1973) 4.55
Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA (1987) 3.99
Amyloid fibrils from muscle myoglobin. Nature (2001) 3.93
Harvey sarcoma virus: a second murine type C sarcoma virus with rat genetic information. J Virol (1974) 3.92
Friend strain of spleen focus-forming virus: a recombinant between mouse type C ecotropic viral sequences and sequences related to xenotropic virus. J Virol (1977) 3.70
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet (1988) 3.37
A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. N Engl J Med (1992) 3.34
Separation of sarcoma virus-specific and leukemia virus-specific genetic sequences of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1975) 3.28
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25
Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. J Immunol (1972) 3.23
Physical assay and growth cycle studies of a defective adeno-satellite virus. J Virol (1967) 3.15
Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide. Proc Natl Acad Sci U S A (1972) 2.90
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA (1988) 2.86
Immunological characterization of primate C-type virus reverse transcriptases. Nat New Biol (1972) 2.73
Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med (1989) 2.72
Type C particle-positive and type C particle-negative rat cell lines: characterization of the coding capacity of endogenous sarcoma virus-specific RNA. J Virol (1976) 2.67
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med (1995) 2.66
Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol (1972) 2.65
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Isolation of a fibroblast nonproducer cell line containing the Friend strain of the spleen focus-forming virus. Virology (1977) 2.47
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med (1983) 2.45
Deletion mapping of moloney type C virus: polypeptide and nucleic acid expression in different transforming virus isolates. J Virol (1976) 2.39
RNA dependent DNA polymerase activity in mammalian cells. Nature (1971) 2.37
HIV seropositivity of needles from shooting galleries in south Florida. Am J Public Health (1990) 2.37
Dexamethasone stimulation of murine mammary tumor virus expression: a tissue culture source of virus. Science (1974) 2.34
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine. Lancet (1987) 2.30
Steroid induction of mouse mammary tumor virus: effect upon synthesis and degradation of viral RNA. J Virol (1977) 2.26
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study. Ann Intern Med (1992) 2.19
Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Am J Med (1991) 2.14
Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13
HIV-infected parents and their children in the United States. Am J Public Health (2000) 2.13
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol (1998) 2.12
Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol (1967) 2.10
Acquired immunodeficiency syndrome in infants. N Engl J Med (1984) 2.09
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med (1997) 2.06
Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis (1994) 2.06
Ultrastructural localization of intracellular immune globulins in plasma cells and lymphoblasts by enzyme-labeled antibodies. J Histochem Cytochem (1969) 2.00
Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol (1990) 1.94
Comparative evaluation of piperacillin in vitro. Antimicrob Agents Chemother (1978) 1.92
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc Natl Acad Sci U S A (1971) 1.86
Levels of rat cellular RNA homologous to either Kirsten sarcoma virus or rat type-C virus in cell lines derived from Osborne-Mendel rats. J Virol (1974) 1.86
Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.80
Mammary tumor virus induction by glucocorticoids. Characterization of specific transcriptional regulation. J Biol Chem (1975) 1.76
Biochemical and physiological mechanisms in glucocorticoid hormone induction of mouse mammary tumor virus. Virology (1976) 1.74
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med (1990) 1.71
HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet (1990) 1.70
Analysis of the factors concerned in the organization of occlusive thrombi. Arch Pathol (1969) 1.66
Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA (1991) 1.62
Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst (1987) 1.62
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med (1993) 1.62
Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med (1990) 1.61
Partial transcription of murine type C viral genomes in BALB c cell lines. J Virol (1973) 1.61
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol (1993) 1.61
Reverse transcriptases of primate viruses as immunological markers. Science (1972) 1.61
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med (1992) 1.53
High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.53
Murine leukaemia virus group-specific antigen in the C-type virus-containing human cell line, ESP-1. Nature (1971) 1.53
Immunochemical characterization of two major polypeptides from murine mammary tumor virus. J Virol (1974) 1.52
Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol (1987) 1.51
CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. AIDS (1998) 1.49
A biochemical and genetic analysis of mammalian RNA-containing sarcoma viruses. Cold Spring Harb Symp Quant Biol (1975) 1.49
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.48
Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers. Psychiatr Serv (1998) 1.48
An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med (1981) 1.45
Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. Int J Neurosci (1996) 1.45
Quantitative analysis of the rescue of RNA sequences by mammalian type C viruses. J Virol (1975) 1.42
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). Antimicrob Agents Chemother (2000) 1.42
RNA dependent DNA polymerase in primate syncytium-forming (foamy) viruses. Nature (1971) 1.42
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med (1993) 1.42
Micronutrients and HIV-1 disease progression. AIDS (1995) 1.41
Cognition and immune function in HIV-1 infection. AIDS (1992) 1.41
Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure. J Pediatr (1995) 1.40
When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr (2000) 1.39
Prostate cancer in relation to the use of electric blanket or heated water bed. Epidemiology (1999) 1.38